Optimal treatment scheduling of ionizing radiation and sunitinib improves the antitumor activity and allows dose reduction

The combination of radiotherapy with sunitinib is clinically hampered by rare but severe side effects and varying results with respect to clinical benefit. We studied different scheduling regimes and dose reduction in sunitinib and radiotherapy in preclinical tumor models to improve potential outcom...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Med
Asıl Yazarlar: Kleibeuker, Esther A, ten Hooven, Matthijs A, Castricum, Kitty C, Honeywell, Richard, Griffioen, Arjan W, Verheul, Henk M, Slotman, Ben J, Thijssen, Victor L
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Ltd 2015
Konular:
Clinical Cancer Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4529339/
https://ncbi.nlm.nih.gov/pubmed/25828633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.441
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller